Barclays analyst Lauren Lieberman maintained a Sell rating on Clorox (CLX – Research Report) on February 4 and set a price target of $132.00. The company’s shares closed last Friday at $141.41, close to its 52-week low of $140.06.
According to TipRanks.com, Lieberman is a 3-star analyst with an average return of 2.6% and a 54.4% success rate. Lieberman covers the Consumer Goods sector, focusing on stocks such as International Flavors & Fragrances, Coca-Cola Europacific Partners, and Reynolds Consumer Products.
Currently, the analyst consensus on Clorox is a Moderate Sell with an average price target of $150.67, implying a 4.0% upside from current levels. In a report issued on January 26, Credit Suisse also downgraded the stock to Sell with a $160.00 price target.
Clorox’s market cap is currently $17.4B and has a P/E ratio of 71.07.
Based on the recent corporate insider activity of 82 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CLX in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Founded in 1913, California-based The Clorox Co. manufactures and markets consumer and professional products. It operates through four business segments: Health and Wellness, Household, Lifestyle, and International.
Read More on CLX:
- Wall Street Analysts Are Bullish on Top Conglomerates Picks
- Analysts Offer Insights on Technology Companies: Ubiquiti Networks (UI), Cognizant (CTSH) and Cellnex Telecom SA (OtherCLNXF)
- These 3 Stocks Could Be the Next M&A Targets, Say Analysts
- Mueller Water Products (MWA) Gets a Hold Rating from Oppenheimer
- Credit Suisse Sticks to Their Hold Rating for Nestlé SA (NSRGF)